课题基金 / 基金详情

Candida antigens involved in site-specific virulence

Candida antigens involved in site-specific virulence
念珠菌抗原参与位点特异性毒力
批准号:
7687267
负责人:
M. Hong Thi NGUYEN
金额:
$14.39万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

M. Hong Thi NGUYEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In our original project, we successfully adapted In Vivo Induced Antigen Technology (IVIAT) to identify 59 Candida albicans genes that are preferentially expressed during oral thrush among HIV-infected patients compared to during growth in vitro. Seven of these in vivo induced genes were previously known to encode candida virulence factors. More importantly, we demonstrated that two previously unrecognized genes, NOT5 and IPF15632, encode novel virulence factors. Of particular note, we found that NOT5 is necessary for normal hyphal formation and complete virulence during both murine oropharyngeal and disseminated candidiasis (OPC and DC, respectively). C. albicans IPF15632, on the other hand, encodes a hypothetical protein that we showed to be necessary for virulence during OPC but not DC. These findings suggest that C. albicans possess virulence-associated genes that contribute to pathogenesis at multiple sties of infection, as well as virulence genes that are tissue-specific. We will now systematically test several of our newly identified in vivo induced genes for their potential roles in pathogenesis at diverse tissue sites. In addition, we will demonstrate that the proteins encoded by the in vivo induced genes are indeed present at different tissue sites during candidiasis. Finally, we will assess the antibody responses to in vivo induced antigens among patients with different types of candidiasis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Within-patient Candida auris strain diversity in a tertiary hospital
Antibiotic resistance among hypermutator carbapenem resistant Klebsiella pneumoniae
Antibiotic resistance among hypermutator carbapenem resistant Klebsiella pneumoniae
Genomic diversity of Candida bloodstream infections
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究